Promethera Biosciences Competitors and Similar CompaniesClear all

Gilead Sciences's competitors and similar companies include Genfit and Pfizer.

	Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.	Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Founding Date	Founding Date 1987	Founding Date 1999	Founding Date 1849
Type	Type Public	Type Public	Type Public
Tags	Tags Manufacturing & Industrial biotech clinical research drug development pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more	Locations Loos, FR HQ Cambridge, US	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more
Employees	Employees 18,0006% increase	Employees 180	Employees 81,0008% decrease
Valuation ($)	Valuation ($) 110.5 b	Valuation ($) 280.8 m	Valuation ($) 163.9 b
Financial
Revenue (est.)	Revenue (est.) $29.4b (FY, 2025)	Revenue (est.) €65.4m (FY, 2025)	Revenue (est.) $62.6b (FY, 2025)
Cost of goods	Cost of goods $6.2b (FY, 2025)	Cost of goods €302k (FY, 2025)	Cost of goods $16.1b (FY, 2025)
Gross profit	Gross profit $23.2b (FY, 2025)	Gross profit €70.8m (FY, 2025)	Gross profit $46.5b (FY, 2025)
Net income	Net income $8.5b (FY, 2025)	Net income (€86m) (FY, 2025)	Net income $7.8b (FY, 2025)
Operating ⚠
Countries	Countries 35 (FY, 2021)	Countries N/A	Countries 200 (FY, 2024)
Phase III Trials Products	Phase III Trials Products 9 (FY, 2021)	Phase III Trials Products N/A	Phase III Trials Products 32 (FY, 2024)